Evaluation of cellular immune responses in subjects chronically infected with HIV type 1

AIDS Research and Human Retroviruses

Volumn 23, Issue 1, 2007, Pages 67-76

  Fu, Tong Ming ^a   Dubey, Sheri A ^a   Mehrotra, Devan V ^a   Freed, Daniel C ^a   Trigona, Wendy L ^a   Adams Muhler, Lisa ^a   Clair, James H ^a   Evans, Thomas G ^b,h   Steigbigel, Roy ^e   Jacobson, Jeffrey M ^d,i   Goepfert, Paul A ^c   Mulligan, Mark J ^c,m   Kalams, Spyros A ^g,j   Rinaldo Jr , Charles ^f   Zhu, Lan ^a   Cox, Kara S ^a   Guan, Liming ^a   Long, Romnie ^a   Persaud, Natasha ^a   Caulfield, Michael J ^a   Sadoff, Jerald C ^a,k   Emini, Emilio A ^a,l   Thaler, Scott ^a   Shiver, John W ^a   more..

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d MOUNT SINAI HOSPITAL   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h Norvatis Institute of Biomedical Research   (United States)

ⁱ DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^j VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Aeras Global TB Vaccine Foundation   (United States)

^l PFIZER INC   (United States)

^m EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; NEF PROTEIN; POL PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; VACCINATION;

ADULT; AFRICAN AMERICANS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLOW CYTOMETRY; GENE PRODUCTS, GAG; GENE PRODUCTS, NEF; GENE PRODUCTS, POL; GENE PRODUCTS, TAT; HISPANIC AMERICANS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; MALE; RNA, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 33846781570     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.0114     Document Type: Article

References (44)

1. Letvin NL and Walker BD: Immunopathogenesis and immunotherapy in AIDS virus infections. Nat Med 2003;9:861-866.
2. Shiver JW and Emini EA: Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu Rev Med 2004;55:355-372.
3. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110.
4. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655.
5. Moore CB, John M, James IR, Christiansen FT, Witt CS, and Mallal SA: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002;296:1439-1443.
6. Kiepiela P, Leslie AJ, Honeyborne I, et al.: Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004;432:769-775.
7. Leslie AJ, Pfafferott KJ, Chetty P, et al.: HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004;10:282-289.
8. Klein MR, van Baalen CA, Holwerda AM, et al.: Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372.
9. Goulder PJ, Phillips RE, Colbert RA, et al.: Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997;3:212-217.
10. Borrow P, Lewicki H, Wei X, et al.: Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [see comments]. Nat Med 1997;3:205-211.
11. Kuroda MJ, Schmitz JE, Charini WA, et al.: Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol 1999;162:5127-5133.
12. Evans DT, O'Connor DH, Jing P, et al.: Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med 1999;5:1270-1276.
13. Allen TM, O'Connor DH, Jing P, et al.: Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [see comments]. Nature 2000;407:386-390.
14. Price DA, West SM, Betts MR, et al.: T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity 2004;21:793-803.
15. Schmitz JE, Kuroda MJ, Santra S, et al.: Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283:857-860.
16. Jin X, Bauer DE, Tuttlelon SE, et al.: Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999;189:991-998.
17. Barouch DH, Santra S, Schmitz JE, et al.: Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000;290:486-492.
18. Amara RR, Villinger F, Altman JD, et al.: Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001;292:69-74.
19. Shiver JW, Fu TM, Chen L, et al.: Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002;415:331-335.
20. Ogg GS, Jin X, Bonhoeffer S, et al.: Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-2106.
21. + T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 2002;76:2298-2305.
22. Novitsky V, Gilbert P, Peter T, et al.: Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol 2003;77:882-890.
23. Betts MR, Ambrozak DR, Douek DC, et al.: Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: Relationship to viral load in untreated HIV infection. J Virol 2001;75:11983-11991.
24. Addo MM, Yu XG, Rathod A, et al.: Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003;77:2081-2092.
25. Fu T-M, Freed DC, Trigona WL, et al.: Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus. J Virol 2001;75:73-82.
26. Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
27. Altfeld M, Addo MM, Eldridge RL, et al.: Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol 2001;167:2743-2752.
28. Novitsky V, Cao H, Rybak N, et al.: Magnitude and frequency of cytotoxic T-lymphocyte responses: Identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol 2002;76:10155-10168.
29. Bansal A, Gough E, Sabbaj S, et al.: CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. AIDS 2005;19:241-250.
30. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression [see comments]. Nat Med 1999;5:518-525.
31. + T cell responses associated with control of viremia [see comments]. Science 1997;278:1447-1450.
32. Coplan PM, Gupta SB, Dubey SA, et al.: Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis 2005;191:1427-1434.
33. Yusim K, Kesmir C, Gaschen B, et al.: Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 2002;76:8757-8768.
34. Altfeld M, Addo MM, Shankarappa R, et al.: Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol 2003;77:7330-7340.
35. Zuniga R, Lucchetti A, Galvan P, et al.: Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 2006;80:3122-3125.
36. + T cells: Correlation with viral load. J Virol 2004;78:3233-3243.
37. O'Connor DH, Allen TM, Vogel TU, et al.: Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med 2002;8:493-499.
38. Appay V, Nixon DF, Donahoe SM, et al.: HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000;192:63-75.
39. + T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002;3:1061-1068.
40. Dagarag M, Ng H, Lubong R, Effros RB, and Yang OO: Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol 2003;77:3077-3083.
41. Appay V, Dunbar PR, Callan M, et al.: Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002;8:379-385.
42. Picker LJ and Maino VC: The CD4(+) T cell response to HIV-1. Curr Opin Immunol 2000;12:381-386.
43. Zajac AJ, Blattman JN, Murali-Krishna K, et al.: Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998;188:2205-2213.
44. Barber DL, Wherry EJ, Masopust D, et al.: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439:682-687.